Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Not yet recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

not_yet_recruiting250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Effect of Pulse Oximeter Device on Measured Perfusion Index Values

NCT06635018
not_yet_recruitingnot_applicable

Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes

NCT07096037
not_yet_recruitingnot_applicable

Comparison of Perfusion Index Monitoring Using a Smartwatch and a Pulse Oximeter

NCT06626217
completed

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

NCT02184117

Clinical Trials (4)

Showing 4 of 4 trials
NCT06635018Not Applicable

Effect of Pulse Oximeter Device on Measured Perfusion Index Values

Completed
NCT07096037Not Applicable

Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes

Not Yet Recruiting
NCT06626217Not Applicable

Comparison of Perfusion Index Monitoring Using a Smartwatch and a Pulse Oximeter

Not Yet Recruiting
NCT02184117

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4